NPI: 1972867513 · ALLENTOWN, PA 18106 · 152W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 44 | $90.77 |
| 2019 | 47 | $388.86 |
| 2020 | 1,831 | $49K |
| 2021 | 7,447 | $239K |
| 2022 | 7,191 | $223K |
| 2023 | 6,606 | $240K |
| 2024 | 3,120 | $94K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92014 | 5,166 | 5,046 | $199K | |
| 92012 | 3,308 | 3,140 | $110K | |
| 67028 | 1,428 | 1,009 | $84K | |
| 92004 | 1,455 | 1,437 | $67K | |
| V2199 | Lens single vision not oth c | 2,328 | 830 | $62K |
| V2020 | Vision svcs frames purchases | 3,799 | 3,120 | $60K |
| V2103 | Spherocylindr 4.00d/12-2.00d | 1,587 | 795 | $57K |
| 66984 | 130 | 92 | $55K | |
| 92134 | 1,926 | 1,818 | $41K | |
| J0178 | Aflibercept injection | 138 | 108 | $26K |
| V2100 | Lens spher single plano 4.00 | 376 | 315 | $22K |
| V2784 | Lens polycarb or equal | 2,949 | 1,041 | $21K |
| 92250 | 452 | 439 | $19K | |
| J9035 | Bevacizumab injection | 296 | 230 | $4K |
| 92002 | 101 | 101 | $4K | |
| 92133 | 131 | 129 | $4K | |
| V2299 | Lens bifocal speciality | 92 | 42 | $3K |
| 99204 | 18 | 18 | $2K | |
| 92083 | 26 | 26 | $1K | |
| 99214 | 26 | 26 | $1K | |
| 92020 | 70 | 70 | $973.49 | |
| V2203 | Lens sphcyl bifocal 4.00d/.1 | 23 | 13 | $854.37 |
| 92060 | 20 | 20 | $738.83 | |
| 99213 | 25 | 25 | $609.50 | |
| 92136 | 38 | 24 | $410.33 | |
| S0500 | Dispos cont lens | 12 | 12 | $265.00 |
| 76514 | 26 | 26 | $208.78 | |
| 92202 | 13 | 12 | $105.23 | |
| V2744 | Tint photochromatic lens/es | 167 | 96 | $60.00 |
| V2750 | Anti-reflective coating | 160 | 90 | $0.00 |